2.3817
8.91%
0.1917
Handel nachbörslich:
2.35
-0.0317
-1.33%
Schlusskurs vom Vortag:
$2.19
Offen:
$2.23
24-Stunden-Volumen:
1.87M
Relative Volume:
1.73
Marktkapitalisierung:
$27.91M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-23.36M
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+42.83%
1M Leistung:
+95.51%
6M Leistung:
+4.84%
1J Leistung:
-87.18%
Calidi Biotherapeutics Inc Stock (CLDI) Company Profile
Firmenname
Calidi Biotherapeutics Inc
Sektor
Branche
Telefon
(858) 794-9600
Adresse
4475 Executive Drive, Suite 200, San Diego
Vergleichen Sie CLDI mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
CLDI | 2.3817 | 27.91M | 0 | -23.36M | 0 | 0.00 |
VRTX | 467.12 | 119.83B | 10.63B | -479.80M | -1.35B | 13.33 |
REGN | 762.38 | 83.28B | 13.85B | 4.65B | 3.32B | 35.06 |
ARGX | 567.35 | 33.74B | 1.86B | -40.29M | -1.28B | -4.16 |
ALNY | 232.27 | 30.38B | 2.09B | -332.26M | 16.06M | -4.14 |
BNTX | 101.83 | 24.08B | 3.30B | -501.07M | 1.03B | 11.54 |
Calidi Biotherapeutics Inc Aktie (CLDI) Neueste Nachrichten
Calidi Biotherapeutics Presents Data Supporting RTNova Systemic Technology to Target Metastatic Lung Cancer - EIN News
Calidi Bio's RTNova Shows Promise in Metastatic Lung Cancer Treatment Breakthrough | CLDI Stock News - StockTitan
Calidi Biotherapeutics Announces Closing of $7.5 Million Public Offering of Common Stock - The Manila Times
Calidi Biotherapeutics Raises $7.5M Through Public Offering of 4.4M Shares | CLDI Stock News - StockTitan
SEC Form 424B5 filed by Calidi Biotherapeutics Inc. - Quantisnow
Calidi Biotherapeutics Announces Pricing of $7.5 Million Public Offering of Common Stock - The Manila Times
Calidi Biotherapeutics Raises $7.5M in Public Offering for Clinical Trials | CLDI Stock News - StockTitan
Calidi Biotherapeutics Surges on 3Q Report, Retreats on Stock-Offer News - MarketWatch
Calidi Biotherapeutics plans stock offering - Investing.com India
Calidi Biotherapeutics Announces Proposed Public Offering - The Manila Times
Calidi Biotherapeutics Launches Public Stock Offering to Fund Corporate Growth | CLDI Stock News - StockTitan
Calidi Biotherapeutics Reports Third Quarter 2024 Operating and Financial Results - The Manila Times
Calidi Bio Gets FDA Nod for Brain Cancer Drug Trial Amid $5.1M Q3 Loss | CLDI Stock | CLDI Stock News - StockTitan
Calidi Biotherapeutics’ $2.1 Million Shares Offering - Global Legal Chronicle
Contrasting BioCryst Pharmaceuticals (NASDAQ:BCRX) & Calidi Biotherapeutics (NYSE:CLDI) - Defense World
CLDICalidi Biotherapeutics, Inc. Latest Stock News & Market Updates - StockTitan
Calidi Biotherapeutics’ (NYSE American: CLDI) Groundbreaking Cancer Treatment on RedChip’s Bloomberg TV Program - Barchart
Nexalin Technology and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - AccessWire
Calidi to present data supporting RTNova at upcoming conferences - TipRanks
Calidi Biotherapeutics to Present Data Supporting RTNova at Upcoming Scientific Conferences - The Manila Times
Calidi to sell 2.05M shares at $1.00 in registered direct offering - Yahoo Finance
Calidi Biotherapeutics stock tumbles on $2M securities offering - MSN
CLDI stock touches 52-week low at $0.95 amid sharp annual decline By Investing.com - Investing.com South Africa
CLDI stock touches 52-week low at $0.95 amid sharp annual decline - Investing.com
Why Calidi Biotherapeutics (CLDI) Stock Is Down 13% - Benzinga
Calidi Biotherapeutics secures $2 million in equity financing - Investing.com
Calidi Biotherapeutics Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement - The Manila Times
Calidi Biotherapeutics Faces Warrant Delisting by NYSE - Yahoo Finance
NYSE American to Commence Delisting Proceedings with Respect to the Warrants of Calidi Biotherapeutics, Inc. (CLDI WS) - The Manila Times
Calidi Biotherapeutics and Gorilla Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - AccessWire
Exchange Income Corp (EIF-T) QuotePress Release - The Globe and Mail
Cocoa #7 (CAU21) Quote - The Globe and Mail
Wendy Pizarro - Los Angeles Times
CLDI stock touches 52-week low at $1 amid market challenges - Investing.com Canada
Adv Micro Devices (AMD-Q) QuotePress Release - The Globe and Mail
Calidi Biotherapeutics Gains FDA Nod for Brain Cancer Trial - TipRanks
Calidi Biotherapeutics Announces FDA Clearance of the Northwestern University IND Application for CLD-101 - U.S. Politics Today
Calidi Biotherapeutics Announces FDA Clearance of the Northwestern University IND Application for CLD-101 Clinical Trial in High-Grade Glioma - The Manila Times
Calidi Biotherapeutics Announces FDA Clearance of the Northwestern University IND Application - The Bakersfield Californian
Calidi Biotherapeutics announces board changes and auditor ratification - Investing.com
Calidi Biotherapeutics Presents Antitumor Virotherapy Advances - TipRanks
Calidi Biotherapeutics stock target cut by Baird with Outperform tag maintained - Investing.com
Calidi price target lowered to $2.50 from $20 at Baird - TipRanks
CLDI Stock Earnings: Calidi Biotherapeutics Beats EPS for Q2 2024 - MSN
Calidi Biotherapeutics Inc (CLDI) Stock: A Year of Highs and Lows in the Market - The InvestChronicle
CLDI Stock Plummets to 52-Week Low at $1.41 Amid Market Turbulence - Investing.com
Calidi Biotherapeutics Unveils Redtail Biopharma Subsidiary - TipRanks
Calidi Biotherapeutics announces board reduction following director's exit By Investing.com - Investing.com South Africa
Calidi Biotherapeutics announces board reduction following director's exit - Investing.com
Calidi Biotherapeutics Board Reshuffles as Advisor Departs - TipRanks
Finanzdaten der Calidi Biotherapeutics Inc-Aktie (CLDI)
Umsatz
Nettogewinn
Free Cashflow
ENV
Kapitalisierung:
|
Volumen (24h):